Dr. Paula Raffin Pohlmann M.D.
Hematologist-Oncologist | Hematology & Oncology
2601 Tvc Nashville TN, 37232About
Dr. Paula Pohlmann is a hematologist oncologist practicing in Nashville, TN. Dr. Pohlmann specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Induction of p53 up-regulated modulator of apoptosis messenger RNA by chemotherapeutic treatment of locally advanced breast cancer.
- Accuracy of frozen-section analysis in the diagnosis of ovarian tumors: a systematic quantitative review.
- Tumor size as a surrogate end point for the detection of early breast cancer: a 30-year (1972-2002), single-center experience in southern Brazil.
- Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLPD?
- Adjuvant platinum-based chemotherapy for early stage cervical cancer.
- Resistance to Trastuzumab in Breast Cancer.
- Insulin-like growth factor-1 receptor inhibitor, AMG-479, in cetuximab-refractory head and neck squamous cell carcinoma.
- Adjuvant platinum-based chemotherapy for early stage cervical cancer.
- Optical metabolic imaging of treatment response in human head and neck squamous cell carcinoma.
- Adjuvant platinum-based chemotherapy for early stage cervical cancer.
- Extended Adjuvant Endocrine Therapy for Postmenopausal Women: Treating Many to Benefit a Few.
- Characteristics and outcomes of breast cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase I clinical trials.
- [Mortality from uterine cervix cancer in Rio Grande do Sul].
Clinical Trials
- Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer
- Diarrhea Prevention and Prophylaxis With Crofelemer in HER2 Positive Breast Cancer Patients
- Phase 2 Study of Tucatinib vs Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer
- Phase 1 Safety Study of ACT-PFK-158, 2HCl in Patients With Advanced Solid Malignancies
Dr. Paula Raffin Pohlmann M.D.'s Practice location
Dr. Paula Raffin Pohlmann M.D.'s reviews
Write ReviewPatient Experience with Dr. Pohlmann
Recommended Articles
- How Immunotherapy Makes a Real Difference in Relapsed Hodgkin Lymphoma
Hodgkin lymphoma, which affects about 0.2% of the people in the United States, is often treated using a combination of chemotherapy, radiation therapy, and stem cell transplant. Sometimes these treatments fail to halt the progress of the disease, and in other cases the cancer seems to halt but then...
- Little Boy Tugs at Heartstrings of Entire Community: Be the Match!
Danny Feltwell, a young six-year-old boy, was diagnosed with T-cell lymphoblastic lymphoma when he was just two years old. After undergoing countless procedures and just four months from being considered fully cured, Danny relapsed and had to be re-hospitalized. The doctors found that a large tumor...
- Seven-year-old Lymphoma Ninja Warrior Fights Through 500 Days of Chemo
In some ways, Von Kleiv is an ordinary 7-year-old boy. He goes to Welch Elementary School in Dover, Delaware. He’s in second grade. He’s getting into karate, and just broke his first wooden board at his first demonstration. People know him as a boy warrior with a strong spirit. He is optimistic,...
- New Study Discovers How Lymphoma Affects Survivors’ Ability to Work
Young adults in many countries pride themselves on their work. They have worked hard to get to where they are and there is a huge sense of accomplishment in joining the adult world and being able to provide for themselves and their new families if applicable. When cancer comes along, their ability...
- Potential Causes of Leukopenia
IntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...
- The Link Between Melatonin and Lymphoma
There’s always room for improvement when it comes to the experience and outcomes of cancer treatment. Fortunately, scientists are constantly researching new, better ways to do so. Although standard treatment remains mostly the same for now, the medical community is making great strides in...
Nearby Providers
- Wendy K. Rathmell2220 Pierce Ave Nashville Tennessee 37232
- Dr. Denise A Yardley M.D.250 25th Ave N Nashville TN 37203
- Dr. Igor Puzanov MD3601 The Vanderbilt Clinic Nashville TN 37232
- Dr. Michael B Hemphill MD5653 Frist Blvd Hermitage TN 37076
- Dr. Edward Kirk Barnes M.D.3443 Dickerson Pike Nashville TN 37207
- Dr. Jesus G Berdeja M.D.250 25th Ave N Nashville TN 37203